# clm_60D18C4ED290

subject: Abbott Laboratories (/record/abbott-laboratories.md)  
predicate: quarterly_revenue  
value: 9,964,000,000 United States dollar  
valid_from: 2024-03-31  
valid_to: 2024-06-30  
published: 2024-05-02  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_BC21405CF5E5  
last_updated: 2026-11-08  
cite: AsOf. "Abbott Laboratories quarterly revenue: 9,964,000,000 United States dollar", as of 2024-03-31 (until 2024-06-30). Claim clm_60D18C4ED290, https://asof.is/claim/clm_60D18C4ED290, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/0001628280-24-020011-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2024, filed 2024-05-02  

## Sources

- https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/0001628280-24-020011-index.htm (primary, SEC EDGAR 10-Q Q1 FY2024, published 2024-05-02)

## Supersedes

- [Abbott Laboratories](/record/abbott-laboratories.md) | quarterly_revenue | 10,143,000,000 United States dollar | valid 2023-09-30 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_60D18C4ED290](/claim/clm_60D18C4ED290.md) | [clm_3885AF18E04D](/claim/clm_3885AF18E04D.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.